Lance Grady

Lance Grady devises commercialization strategies focused on value, access, and reimbursement.

With a focus on oncology and over 20 years of experience in policy, access,  reimbursement strategy and execution, and point-of-care, he is passionate about providing practical and meaningful solutions that are viable to all healthcare stakeholders. Lance delivers proven, measurable outcomes by creating integrative and sustainable solutions in functional areas pertaining to: patient access strategy and services; physician-administered reimbursement strategy and support; value-based and risk-based payment models; CMS policy strategy; Medicare payment models; commercial health plan formulary, medical policy, and utilization management; benefit design; drug-dollar-data flow; oncology pathways; specialty channel strategies—pharmacy, GPO, and wholesaler distribution.

Prior, Lance enjoyed a successful 12-year career at Bristol-Myers Squibb in various leadership roles in U.S. Market Access. He also has experience in orphan drug and autoimmune therapeutic markets.

He is a graduate of the University of Louisiana-Monroe where he studied human biology and immunobiology.

Authored Content

Avalere experts examine the current drug pricing policy landscape and what potential changes stakeholders should prepare for.

Reforms to “eliminate rebates” could have varying impacts based on features of their design.